ViaCord Nabs Rights to TRT’s Platform for Extracting Stem Cells from Cord Tissue ViaCord® negotiated exclusive U.S. rights to Tissue Regeneration Therapeutics’ (TRT) human umbilical cord perivascular cell technology for extracting mesenchymal stem cells from the tissue surrounding umbilical cord vessels. [Genetic Engineering & Biotechnology News] Press Release Cord Blood America Growing Stem Cell Storage Business through Referrals Cord Blood America, Inc. announced that since it launched a Referral Rewards Program on July 7, 2011, referral sales have risen from 8 to 21 percent of total sales. [Cord Blood America, Inc.] Press Release Cryo-Save Group N.V. – Strong Third Quarter Results Cryo-Save Group N.V. announced its trading update for the quarter ended 30 September 2011. [Cryo-Save Group N.V.] Press Release Golden Meditech Chairman Increases Stake in Company Golden Meditech Holdings Limited announced that the Group’s Chairman, Mr. KAM Yuen, and his family have purchased 53,828,000 shares of the Company from the open market on the disclosure date (October 27, 2011), at the average price of HK$0.85 per share via a representative holding company, as per disclosed to the Hong Kong Exchanges and Clearings Limited. [Golden Meditech Holdings Limited] Press Release |